Vaccinex (VCNX) Stock Chart & Stock Price History $0.94 -0.05 (-5.05%) As of 07/11/2025 03:53 PM Eastern Add Compare Share Share Chart Stock AnalysisChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Vaccinex Stock Price Performance The Vaccinex (VCNX) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has decreased 85.70%, with a year-to-date return of -4.08%. In the past month, the stock has increased 17.94%, reflecting recent market activity. As of the latest close, Vaccinex traded at $0.94 with a market cap of $2.44 million and volume of 228 shares. Five years ago, the stock traded at a split-adjusted price of $829.50, representing a 99.89% decrease over that period. At the time, it had a market cap of $59.92 million and a volume of 2,253 shares. Receive VCNX Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Vaccinex and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance+17.50%1 Month Performance+17.94%3 Month Performance+34.65%Year-To-Date Performance-4.08%1 Year Performance-85.70%5 Year Performance-99.89% VCNX Stock Chart for Saturday, July, 12, 2025 VCNX Chart by TradingView Vaccinex Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization07/11/2025$0.99$0.94-5.05%$0.94$0.94228 shs$2.44 million07/10/2025$0.89$0.99+11.24%$0.99$0.95625 shs$2.57 million07/09/2025$0.89$0.89$0.89$0.89153 shs$2.31 million07/08/2025$0.80$0.89+11.25%$0.89$0.89153 shs$2.31 million07/07/2025$0.70$0.80+14.37%$0.80$0.704,070 shs$2.08 million07/04/2025$0.70$0.70$0.73$0.581,921 shs$1.82 million07/03/2025$0.73$0.70-4.18%$0.73$0.581,921 shs$1.82 million07/02/2025$0.75$0.73-2.67%$0.75$0.73691 shs$1.90 million07/01/2025$0.73$0.75+2.74%$0.75$0.75117 shs$1.95 million06/30/2025$0.73$0.73$0.75$0.60826 shs$1.90 million Get the Latest News and Ratings for VCNX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Vaccinex and its competitors with MarketBeat's FREE daily newsletter. 06/27/2025$0.80$0.73-8.75%$0.80$0.587,547 shs$1.90 million06/26/2025$0.80$0.80$0.80$0.80280 shs$2.08 million06/25/2025$0.66$0.80+21.21%$0.80$0.80280 shs$2.08 million06/24/2025$0.78$0.66-15.38%$0.66$0.66519 shs$1.72 million06/23/2025$0.71$0.78+9.86%$0.80$0.5711,823 shs$2.03 million06/20/2025$0.71$0.71$0.71$0.7154 shs$1.85 million06/19/2025$0.71$0.71$0.71$0.7154 shs$1.85 million06/18/2025$0.71$0.71$0.71$0.7138 shs$1.85 million06/17/2025$0.71$0.71$0.72$0.713,555 shs$1.85 million06/16/2025$0.82$0.71-13.41%$0.72$0.713,555 shs$1.85 million06/13/2025$0.80$0.82+2.89%$0.82$0.821,046 shs$2.13 million06/12/2025$0.80$0.80$0.80$0.73687 shs$2.07 million06/11/2025$0.88$0.80-9.23%$0.80$0.73687 shs$2.07 million Related Companies BMRA Stock Chart TCRT Stock Chart TRAW Stock Chart OBSV Stock Chart GOVX Stock Chart CLDI Stock Chart PMCB Stock Chart LIXT Stock Chart ORGS Stock Chart GNPX Stock Chart Receive VCNX Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Vaccinex and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:VCNX) was last updated on 7/12/2025 by MarketBeat.com Staff From Our Partners3..2..1.. AI 2.0 ignition (don’t sleep on this)I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredBuffett’s $325 Billion Cash Problem — Solved by Gold?A bombshell announcement is just weeks away — and it could send shockwaves through the gold market. Most inves...Golden Portfolio | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredThe End of Elon Musk…?The End of Elon Musk? Don't make him laugh. Jeff Brown has been hearing this same tired story for years, an...Brownstone Research | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.Something big is brewing in Washington. According to my research, an executive order from President Trump c...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Vaccinex, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Vaccinex With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.